Genomic Evolution and Resistance during Pirtobrutinib Therapy in Covalent BTK-Inhibitor (cBTKi) Pre-Treated Chronic Lymphocytic Leukemia Patients: Updated Analysis from the BRUIN Study

被引:19
作者
Brown, Jennifer R. [1 ,2 ]
Desikan, Sai Prasad [3 ]
Nguyen, Bastien [4 ]
Won, Helen [4 ]
Tantawy, Shady I.
McNeely, Samuel [6 ]
Marella, Narasimha [4 ]
Ebata, Kevin [4 ]
Woyach, Jennifer A. [3 ]
Patel, Krish [7 ]
Tam, Constantine S. [8 ]
Eyre, Toby A. [9 ]
Cheah, Chan Y. [10 ,11 ]
Shah, Nirav N. [12 ]
Ghia, Paolo [14 ]
Jurczak, Wojciech [15 ]
Balbas, Minna [4 ]
Nair, Binoj [4 ]
Abada, Paolo [4 ,13 ]
Wang, Chunxiao [6 ]
Wang, Ying [4 ]
Roeker, Lindsey E. [16 ]
Gandhi, Varsha [17 ]
Wierda, William G. [5 ]
机构
[1] Harvard Med Sch, Div Med Oncol, Chron Lymphocyt Leukemia Ctr, Boston, MA USA
[2] Dana Farber Canc Inst, Boston, MA USA
[3] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH USA
[4] Loxo Lilly, Indianapolis, IN USA
[5] MD Anderson Canc Ctr, Houston, TX USA
[6] Eli Lilly & Co, Indianapolis, IN USA
[7] Swedish Canc Inst, Seattle, WA USA
[8] Alfred Hlth & Monash Univ, East Melbourne, Alfred, NY, Australia
[9] Oxford Univ Hosp NHS Fdn Trust, Churchill Canc Ctr, Oxford, England
[10] Linear Clin Res, Perth, Australia
[11] Sir Charles Gairdner Hosp, Perth, Australia
[12] Med Coll Wisconsin, Milwaukee, WI USA
[13] Univ Vita Salute San Raffaele, Milan, Italy
[14] IRCCS Osped San Raffaele, Milan, Italy
[15] Maria Sklodowska Curie Natl Res Inst Oncol, Krakow, Poland
[16] Mem Sloan Kettering Canc Ctr, New York, NY USA
[17] Univ Texas MD Anderson Canc Ctr Houston, Dept Expt Therapeut, Houston, TX USA
关键词
D O I
10.1182/blood-2023-180143
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:6
相关论文
empty
未找到相关数据